Dr. Barry Dworkin

New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented

Madely Health Headlines Commentary for December 9, 2014

[display_podcast]

Source:

New drug gives adults cholesterol levels of a baby

Reference:

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Related posts:

  1. Are US statin guidelines being too inclusive and leading to overtreatment?
  2. New U.S guidelines for statin use for everyone over 40 needs careful consideration of risks vs benefits and is certainly not for everyone
  3. Observational study about heart health classification likely overstates depth of problem
  4. Implications of major study on stents for heart disease could change guidelines favouring medication alone for certain patients